| Literature DB >> 31237352 |
Varoona Bizaoui1, Caroline Michot1, Geneviève Baujat1, Cyril Amouroux2, Sabine Baron3, Yline Capri4, Martine Cohen-Solal5, Corinne Collet6, Anne Dieux7, David Geneviève8, Bertrand Isidor3, Sophie Monnot1, Massimiliano Rossi9,10, Anya Rothenbuhler11, Elise Schaefer12, Valérie Cormier-Daire1.
Abstract
Pycnodysostosis is a lysosomal autosomal recessive skeletal dysplasia characterized by osteosclerosis, short stature, acro-osteolysis, facial features and an increased risk of fractures. The clinical heterogeneity of the disease and its rarity make it difficult to provide patients an accurate prognosis, as well as appropriate care and follow-up. French physicians from the OSCAR network have been asked to fill out questionnaires collecting molecular and clinical data for 27 patients issued from 17 unrelated families. All patients showed short stature (mean = -3.5 SD) which was more severe in females (P = .006). The mean fracture rate was moderate (0.21 per year), with four fractures in total average. About 75% underwent at least one surgery, with an average number of 2.1 interventions per patient. About 50% required non-invasive assisted ventilation due to sleep apnea (67%). About 29% showed psychomotor difficulties and 33% needed a school assistant or adapted schooling. No patient had any psychological evaluation or follow-up. Molecular data were available for 14 families. Growth hormone administration was efficient on linear growth in 40% of cases. We propose several axis of management, such as systematic cerebral MRI for Chiari malformation screening at diagnosis and regular psychological follow-up.Entities:
Keywords: CTSK; bone fragility; osteosclerosis; pycnodysostosis
Year: 2019 PMID: 31237352 DOI: 10.1111/cge.13591
Source DB: PubMed Journal: Clin Genet ISSN: 0009-9163 Impact factor: 4.438